Pulukuri et al. [19] have recently demonstrated that shRNAs for uPA and uPAR almost completely inhibit established orthotopic tumor growth; however, little is known about the expression of uPAR during prostate cancer progression from the orthotopic environment to early metastatic sites. The gene discussed is PLAUR; the disease is neoplasm.